Ovarian cancer-on-chip for patient-specific profiling of treatment responses to sequential chemotherapy and PD-L1 blockade
Sarah Plöger, Nicole Anderle, Eileen Wegner, Tobias Schmidt, Julia Roosz, Tengku Ibrahim Maulana, Lena Christ, Tobias Engler, Andreas Hartkopf, André Koch, Sara Y. Brucker, Katja Schenke‐Layland, André Rosa, Christian Schmees, Peter Loskill
This paper develops an OvCa-on-chip platform to profile patient-specific treatment responses to chemotherapy and PD-L1 blockade.
bioRxiv · Jul 24, 2026 · PreprintCancer Biology